Literature DB >> 28659349

Randomised controlled trial of transanal endoscopic microsurgery versus endoscopic mucosal resection for large rectal adenomas (TREND Study).

Renée M Barendse1, Gijsbert D Musters1, Eelco J R de Graaf2, Frank J C van den Broek3, Esther C J Consten4, Pascal G Doornebosch2, James C Hardwick5, Ignace H J T de Hingh6, Chrisiaan Hoff7, Jeroen M Jansen8, A W Marc van Milligen de Wit9, George P van der Schelling10, Erik J Schoon11, Matthijs P Schwartz12, Bas L A M Weusten13, Marcel G Dijkgraaf14, Paul Fockens15, Willem A Bemelman1, Evelien Dekker15.   

Abstract

OBJECTIVE: Non-randomised studies suggest that endoscopic mucosal resection (EMR) is equally effective in removing large rectal adenomas as transanal endoscopic microsurgery (TEM), but EMR might be more cost-effective and safer. This trial compares the clinical outcome and cost-effectiveness of TEM and EMR for large rectal adenomas.
DESIGN: Patients with rectal adenomas ≥3 cm, without malignant features, were randomised (1:1) to EMR or TEM, allowing endoscopic removal of residual adenoma at 3 months. Unexpected malignancies were excluded postrandomisation. Primary outcomes were recurrence within 24 months (aiming to demonstrate non-inferiority of EMR, upper limit 10%) and the number of recurrence-free days alive and out of hospital.
RESULTS: Two hundred and four patients were treated in 18 university and community hospitals. Twenty-seven (13%) had unexpected cancer and were excluded from further analysis. Overall recurrence rates were 15% after EMR and 11% after TEM; statistical non-inferiority was not reached. The numbers of recurrence-free days alive and out of hospital were similar (EMR 609±209, TEM 652±188, p=0.16). Complications occurred in 18% (EMR) versus 26% (TEM) (p=0.23), with major complications occurring in 1% (EMR) versus 8% (TEM) (p=0.064). Quality-adjusted life years were equal in both groups. EMR was approximately €3000 cheaper and therefore more cost-effective.
CONCLUSION: Under the statistical assumptions of this study, non-inferiority of EMR could not be demonstrated. However, EMR may have potential as the primary method of choice due to a tendency of lower complication rates and a better cost-effectiveness ratio. The high rate of unexpected cancers should be dealt with in further studies. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  cost-effectiveness; endoscopic mucosal resection; rectal adenoma; transanal endoscopic microsurgery

Mesh:

Year:  2017        PMID: 28659349     DOI: 10.1136/gutjnl-2016-313101

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  12 in total

1.  Endomucosal resection of a rectal polyp at the dentate line, an alternative to transanal endoscopic microsurgery.

Authors:  A Le Saint-Grant; M A Potter
Journal:  Tech Coloproctol       Date:  2019-06-11       Impact factor: 3.781

2.  Endoscopic submucosal dissection versus transanal endoscopic surgery for the treatment of early rectal tumor: a systematic review and meta-analysis.

Authors:  Vitor Massaro Takamatsu Sagae; Igor Braga Ribeiro; Diogo Turiani Hourneaux de Moura; Vitor Ottoboni Brunaldi; Fernanda Prado Logiudice; Mateus Pereira Funari; Elisa Ryoka Baba; Wanderley Marques Bernardo; Eduardo Guimarães Hourneaux de Moura
Journal:  Surg Endosc       Date:  2019-11-21       Impact factor: 4.584

Review 3.  Transanal Local Excision or Endoscopic Dissection for Benign and Large Lesions of the Rectum.

Authors:  Mario Morino; Alberto Arezzo
Journal:  Clin Colon Rectal Surg       Date:  2022-02-28

Review 4.  The Role of Transanal Endoscopic Surgery for Early Rectal Cancer.

Authors:  Natalie F Berger; Patricia Sylla
Journal:  Clin Colon Rectal Surg       Date:  2022-02-28

5.  Risk factors for local recurrence of large gastrointestinal lesions after endoscopic mucosal resection.

Authors:  Yasar Colak; Badar Hasan; Walid Hassaballa; Mamoon Ur Rashid; Victor Strassmann; Giovanna DaSilva; Steven D Wexner; Tolga Erim
Journal:  Tech Coloproctol       Date:  2022-05-02       Impact factor: 3.699

6.  Importance of Resection Margins in the Treatment of Rectal Adenomas by Transanal Endoscopic Surgery.

Authors:  Xavier Serra-Aracil; Neus Ruiz-Edo; Alex Casalots-Casado; Laura Mora-López; Anna Pallisera-Lloveras; Sheila Serra-Pla; Vanlentí Puig-Diví; Salvador Navarro-Soto
Journal:  J Gastrointest Surg       Date:  2018-10-10       Impact factor: 3.452

7.  Transanal minimally invasive surgery (TAMIS) versus endoscopic submucosal dissection (ESD) for resection of non-pedunculated rectal lesions (TRIASSIC study): study protocol of a European multicenter randomised controlled trial.

Authors:  Nik Dekkers; Jurjen J Boonstra; Leon M G Moons; Roel Hompes; Barbara A Bastiaansen; Jurriaan B Tuynman; Arjun D Koch; Bas L A M Weusten; Apollo Pronk; Peter A Neijenhuis; Marinke Westerterp; Wilbert B van den Hout; Alexandra M J Langers; Jolein van der Kraan; Alaa Alkhalaf; Jonathan Y L Lai; Frank Ter Borg; Hans Fabry; Eric Halet; Matthijs P Schwartz; Wouter B Nagengast; Jan Willem A Straathof; Rogier W R Ten Hove; Leendert H Oterdoom; Christiaan Hoff; Eric J Th Belt; David D E Zimmerman; Muhammed Hadithi; Hans Morreau; Erienne M V de Cuba; Jeroen W A Leijtens; Hans F A Vasen; Monique E van Leerdam; Eelco J R de Graaf; Pascal G Doornebosch; James C H Hardwick
Journal:  BMC Gastroenterol       Date:  2020-07-13       Impact factor: 3.067

8.  Endoscopic submucosal dissection for rectal neoplasia extending to the dentate line: European experience.

Authors:  Andreas Probst; Alanna Ebigbo; Bruno Märkl; Saskia Ting; Tina Schaller; Matthias Anthuber; Carola Fleischmann; Helmut Messmann
Journal:  Endosc Int Open       Date:  2018-11-07

9.  Safety and efficacy of endoscopic submucosal dissection for rectal neoplasia: a multicenter North American experience.

Authors:  Dennis Yang; Hiroyuki Aihara; Yaseen B Perbtani; Andrew Y Wang; Abdul Aziz Aadam; Yutaka Tomizawa; Joo Ha Hwang; Baiming Zou; Nikola S Natov; Amanda Siegel; Milad Pourmousavi Khoshknab; Mouen A Khashab; Saowanee Ngamruengphong; Harshit S Khara; David L Diehl; Thibaut Maniere; Sherif Andrawes; Petros Benias; Nikhil A Kumta; Fariha Ramay; Raymond E Kim; Jason Samarasena; Kenneth Chang; Rintaro Hashimoto; Benjamin Tharian; Sumant Inamdar; Gloria Lan; Amrita Sethi; Michael J Nosler; Abdalaziz Tabash; Mohamed O Othman; Peter V Draganov
Journal:  Endosc Int Open       Date:  2019-12-02

10.  Histopathological features for coexistent invasive cancer in large colorectal adenomatous polyps.

Authors:  A Emmanuel; A Haji; S Gulati; J Moorhead; S Papagrigoriadis; B Hayee; S Diaz-Cano
Journal:  BJS Open       Date:  2021-05-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.